References
Toussi A, Stewart-Merrill SB, Boorjian SA et al (2016) Standardizing the definition of biochemical recurrence after radical prostatectomy—what prostate specific antigen cut point best predicts a durable increase and subsequent systemic progression? Urology 195(6):1754–1759
Bouchelouche K, Tagawa ST, Goldsmith SJ et al (2011) PET/CT imaging and radioimmunotherapy of prostate cancer. Semin Nucl Med 41(1):29–44
Giesel FL, Kesch C, Yun M et al (2017) 18F-PSMA-1007 PET/CT detects micrometastases in a patient with biochemically recurrent prostate cancer. Clin Genitourin Cancer 15(3):e497–e499
Martinez-Lorca A (2016) The challenge of adequate metastasis detection in the patient with castration-resistant prostate cancer. Rev Mex Urol 76:129–130
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Lorca, A.M. Management of biochemically recurrent prostate cancer: molecular imaging perspective. World J Urol 36, 321–322 (2018). https://doi.org/10.1007/s00345-017-2127-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-017-2127-0